Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway

Nyall R. London; Anuj Tharakan; Ana M. Rule; Andrew P. Lane; Shyam Biswal; Murugappan Ramanathan

doi:10.1016/j.jaci.2016.06.027

Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway

Nyall R. London, Anuj Tharakan, Ana M. Rule, Andrew P. Lane, Shyam Biswal, Murugappan Ramanathan

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1736-1738.e4
Journal	Journal of Allergy and Clinical Immunology
Volume	138
Issue number	6
DOIs	https://doi.org/10.1016/j.jaci.2016.06.027
State	Published - Dec 1 2016

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2016.06.027

Cite this

@article{cba75c6381ae485facde7f4b38bfd6b1,

title = "Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway",

author = "London, {Nyall R.} and Anuj Tharakan and Rule, {Ana M.} and Lane, {Andrew P.} and Shyam Biswal and Murugappan Ramanathan",

note = "Funding Information: Disclosure of potential conflict of interest: N. R. London holds patents for composition and methods for treating pathologic angiogenesis and endothelial hyperpermeability and has stock options with Navigen Pharmaceuticals, which are currently of no value. A. M. Rule has received support from the National Institutes of Health (grant no. K23ES020859). The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.jaci.2016.06.027",

language = "English (US)",

volume = "138",

pages = "1736--1738.e4",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway

AU - London, Nyall R.

AU - Tharakan, Anuj

AU - Rule, Ana M.

AU - Lane, Andrew P.

AU - Biswal, Shyam

AU - Ramanathan, Murugappan

N1 - Funding Information: Disclosure of potential conflict of interest: N. R. London holds patents for composition and methods for treating pathologic angiogenesis and endothelial hyperpermeability and has stock options with Navigen Pharmaceuticals, which are currently of no value. A. M. Rule has received support from the National Institutes of Health (grant no. K23ES020859). The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=84994091722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994091722&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2016.06.027

DO - 10.1016/j.jaci.2016.06.027

M3 - Article

C2 - 27576127

AN - SCOPUS:84994091722

SN - 0091-6749

VL - 138

SP - 1736-1738.e4

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 6

ER -

Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this